# MID Penn Bancorp Inc: financial statements, quarterly

MPB · Nasdaq · CIK 879635 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/mpb.md) · [Financials](/companies/mpb/financials.md) · [Filings](/companies/mpb/filings.md) · [Insiders](/companies/mpb/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/mpb/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Interest expense | $m | [25.9](/filings/0000879635-23-000105.md) | [29.1 d](/filings/0000879635-24-000049.md) | [31.7](/filings/0000879635-24-000112.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [2.3](/filings/0000879635-24-000203.md) | [2.3 d](/filings/0000879635-26-000026.md) | [2.6](/filings/0000879635-25-000109.md) | [2.5](/filings/0000879635-25-000158.md) | [2.6](/filings/0000879635-25-000177.md) | [3.0 d](/filings/0000879635-26-000026.md) | [3.1](/filings/0000879635-26-000035.md) | [(0.5)](/filings/0000879635-26-000051.md) | [6.0](/filings/0000879635-25-000177.md) | [7.6 d](/filings/0000879635-26-000026.md) | [2.6](/filings/0000879635-26-000035.md) | [5.9](/filings/0000879635-26-000051.md) |
| Net income | $m | [9.2](/filings/0000879635-24-000203.md) | [12.1 d](/filings/0000879635-26-000026.md) | [12.1](/filings/0000879635-25-000177.md) | [11.8](/filings/0000879635-25-000177.md) | [12.3](/filings/0000879635-25-000177.md) | [13.2 d](/filings/0000879635-26-000026.md) | [13.7](/filings/0000879635-26-000051.md) | [4.8](/filings/0000879635-26-000051.md) | [18.3](/filings/0000879635-25-000177.md) | [19.4 d](/filings/0000879635-26-000026.md) | [8.7](/filings/0000879635-26-000051.md) | [21.7](/filings/0000879635-26-000051.md) |
| Diluted EPS | $ per share | [0.56](/filings/0000879635-24-000203.md) | not reported | [0.73](/filings/0000879635-25-000109.md) | [0.71](/filings/0000879635-25-000158.md) | [0.74](/filings/0000879635-25-000177.md) | not reported | [0.71](/filings/0000879635-26-000035.md) | [0.22](/filings/0000879635-26-000051.md) | [0.79](/filings/0000879635-25-000177.md) | not reported | [0.36](/filings/0000879635-26-000035.md) | [0.85](/filings/0000879635-26-000051.md) |
| Basic EPS | $ per share | [0.56](/filings/0000879635-24-000203.md) | not reported | [0.73](/filings/0000879635-25-000109.md) | [0.71](/filings/0000879635-25-000158.md) | [0.74](/filings/0000879635-25-000177.md) | not reported | [0.71](/filings/0000879635-26-000035.md) | [0.22](/filings/0000879635-26-000051.md) | [0.80](/filings/0000879635-25-000177.md) | not reported | [0.36](/filings/0000879635-26-000035.md) | [0.86](/filings/0000879635-26-000051.md) |

- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Total assets | $m | [5,216](/filings/0000879635-23-000105.md) | [5,291](/filings/0000879635-25-000030.md) | [5,330](/filings/0000879635-24-000112.md) | [5,392](/filings/0000879635-24-000146.md) | [5,527](/filings/0000879635-24-000203.md) | [5,471](/filings/0000879635-26-000026.md) | [5,546](/filings/0000879635-25-000109.md) | [6,355](/filings/0000879635-25-000158.md) | [6,267](/filings/0000879635-25-000177.md) | [6,134](/filings/0000879635-26-000051.md) | [6,965](/filings/0000879635-26-000035.md) | [7,063](/filings/0000879635-26-000051.md) |
| Total liabilities | $m | [4,687](/filings/0000879635-23-000105.md) | [4,748](/filings/0000879635-25-000030.md) | [4,779](/filings/0000879635-24-000112.md) | [4,832](/filings/0000879635-24-000146.md) | [4,954](/filings/0000879635-24-000203.md) | [4,816](/filings/0000879635-26-000026.md) | [4,878](/filings/0000879635-25-000109.md) | [5,579](/filings/0000879635-25-000158.md) | [5,471](/filings/0000879635-25-000177.md) | [5,320](/filings/0000879635-26-000051.md) | [6,077](/filings/0000879635-26-000035.md) | [6,161](/filings/0000879635-26-000051.md) |
| Short-term borrowings | $m | [139](/filings/0000879635-23-000105.md) | [242](/filings/0000879635-25-000030.md) | [272](/filings/0000879635-24-000112.md) | [200](/filings/0000879635-24-000146.md) | [114](/filings/0000879635-24-000203.md) | [2.0](/filings/0000879635-26-000026.md) | [25.0](/filings/0000879635-25-000109.md) | [0.0](/filings/0000879635-25-000158.md) | [0.0](/filings/0000879635-25-000177.md) | [20.8](/filings/0000879635-26-000051.md) | [31.5](/filings/0000879635-26-000035.md) | [138](/filings/0000879635-26-000051.md) |
| Shareholders' equity | $m | [529](/filings/0000879635-24-000203.md) | [542](/filings/0000879635-26-000026.md) | [551](/filings/0000879635-25-000177.md) | [560](/filings/0000879635-25-000177.md) | [573](/filings/0000879635-25-000177.md) | [655](/filings/0000879635-26-000051.md) | [668](/filings/0000879635-26-000051.md) | [776](/filings/0000879635-26-000051.md) | [796](/filings/0000879635-25-000177.md) | [814](/filings/0000879635-26-000051.md) | [887](/filings/0000879635-26-000051.md) | [902](/filings/0000879635-26-000051.md) |

- Cash and equivalents: not reported
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [13.2 d](/filings/0000879635-24-000203.md) | [14.6 d](/filings/0000879635-26-000026.md) | [12.4](/filings/0000879635-25-000109.md) | [18.0 d](/filings/0000879635-25-000158.md) | [16.9 d](/filings/0000879635-25-000177.md) | [4.1 d](/filings/0000879635-26-000026.md) | [12.5](/filings/0000879635-26-000035.md) | [34.2 d](/filings/0000879635-26-000051.md) | [20.0 d](/filings/0000879635-25-000177.md) | [13.3 d](/filings/0000879635-26-000026.md) | [14.5](/filings/0000879635-26-000035.md) | [32.4 d](/filings/0000879635-26-000051.md) |
| Capital expenditure | $m | [0.9 d](/filings/0000879635-24-000203.md) | [0.1 d](/filings/0000879635-26-000026.md) | [0.4](/filings/0000879635-25-000109.md) | [0.3 d](/filings/0000879635-25-000158.md) | [0.0 d](/filings/0000879635-25-000177.md) | [6.3 d](/filings/0000879635-26-000026.md) | [2.7](/filings/0000879635-26-000035.md) | [1.8 d](/filings/0000879635-26-000051.md) | [1.9 d](/filings/0000879635-25-000177.md) | [1.8 d](/filings/0000879635-26-000026.md) | [1.4](/filings/0000879635-26-000035.md) | [1.2 d](/filings/0000879635-26-000051.md) |
| Dividends paid | $m | [3.3 d](/filings/0000879635-24-000203.md) | [3.3 d](/filings/0000879635-26-000026.md) | [3.3](/filings/0000879635-25-000109.md) | [3.3 d](/filings/0000879635-25-000158.md) | [3.3 d](/filings/0000879635-25-000177.md) | [3.9 d](/filings/0000879635-26-000026.md) | [3.9](/filings/0000879635-26-000035.md) | [4.7 d](/filings/0000879635-26-000051.md) | [4.6 d](/filings/0000879635-25-000177.md) | [5.1 d](/filings/0000879635-26-000026.md) | [6.2](/filings/0000879635-26-000035.md) | [5.6 d](/filings/0000879635-26-000051.md) |
| Share repurchases | $m | [0.0 d](/filings/0000879635-24-000203.md) | [0.3 d](/filings/0000879635-26-000026.md) | [0.3](/filings/0000879635-25-000109.md) | [0.0 d](/filings/0000879635-25-000158.md) | [0.0 d](/filings/0000879635-25-000177.md) | [0.0 d](/filings/0000879635-26-000026.md) | [0.0](/filings/0000879635-25-000109.md) | [1.8 d](/filings/0000879635-26-000051.md) | [0.2 d](/filings/0000879635-25-000177.md) | [0.2 d](/filings/0000879635-26-000026.md) | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [15.9](/filings/0000879635-23-000105.md) | [15.9](/filings/0000879635-24-000112.md) | [16.3](/filings/0000879635-24-000146.md) | [16.6](/filings/0000879635-24-000203.md) | [16.6](/filings/0000879635-25-000109.md) | [16.6](/filings/0000879635-25-000158.md) | [16.7](/filings/0000879635-25-000177.md) | [19.4](/filings/0000879635-26-000035.md) | [21.6](/filings/0000879635-26-000051.md) | [23.3](/filings/0000879635-25-000177.md) | [24.3](/filings/0000879635-26-000035.md) | [25.6](/filings/0000879635-26-000051.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 25,335,215 at 2026-07-31, from the cover of the [10-Q filed 2026-08-06](/filings/0000879635-26-000051.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:26 ET. No prices; not investment advice.